On Tuesday, Palantir Technologies Inc. (NYSE:PLTR) shares advanced by more than 4.5% after announcing a partnership with German technology conglomerate Merck Group. The two companies have joined hands to try to find a solution to the unending chip supply shortage in the semiconductor industry.
Should you buy Palantir stock after partnering with Merck to tackle chip shortage?